• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Israeli Government Adopts Touchless Remote Monitoring to Detect COVID-19 Symptoms

by Jasmine Pennic 04/16/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Israeli Government Adopts Touchless Remote Monitoring to Detect COVID-19 Symptoms

What You Should Know:

– Israeli government adopts Vayyar’s 4D imaging sensor solutions to aid in the fight to slow the spread of COVID-19 in health facilities, transportation and activity hubs, private residences and more.

– Vayyar’s intelligent sensors can be placed in homes, hospitals, factories, airports, public transport, borders and more to provide real-time data, and by minimizing the need for face-to-face contact, reduce the risk of exposure for both medical and non-medical personnel.


Vayyar, a Tel Aviv, Israel-based provider of 4D radar imaging, announced today that its life-saving sensor technology is being used by the Israeli government to fight the spread of COVID-19. Vayyar’s intelligent sensors provide touchless, remote and confidential monitoring to detect and monitor vital signs that can indicate early-stage COVID-19 symptoms. The data, including pulse, heart rate variability and respiratory rate, are all measured remotely, without the need for touch.

Vayyar’s intelligent sensors can be placed in homes, hospitals, factories, airports, public transport, borders and more to provide real-time data, and by minimizing the need for face-to-face contact, reduce the risk of exposure for both medical and non-medical personnel.

Vayyar is collaborating with MAFAT (Israel’s Defense Research & Development Directorate) and Israel’s Naval Medical Institute. Vayyar’s sensors have been successfully installed and are monitoring personnel in real-time to help detect early signs of the COVID-19 virus. Separately, The Israel National Emergency Team has successfully completed a test in which two systems were adapted for Vayyar sensors to analyze remotely, the vital data of patients.

“During this global pandemic, we are proud to work with health and defense systems to help control the COVID-19 outbreak, flatten the curve and save the lives of our loved ones,” says Ofer Familier, General Manager of Vayyar Home.  “As we evolve our symptom monitoring capabilities, we hope to provide reassurance in this small way to soften social distancing restrictions, get people back to work and help to revive the economy.” 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Heart, risk, sensors, Vital

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |